Trial · NCT04718961
Adverse events68
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 68
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Part 1 Arm 1 - Volixibat 20mg (Experimental) | 1 | 2 | 1 |
| other | Anemia | Blood and lymphatic system disorders | Part 1 Arm 2 - Volixibat 80mg (Experimental) | 1 | 2 | 1 |
| other | Anemia | Blood and lymphatic system disorders | Part 2 Arm 1 - Volixibat Selected Dose mg (Experimental) | 0 | ||
| other | Anemia | Blood and lymphatic system disorders | Part 2 Arm 2 - Placebo (Placebo Comparator) | 0 | ||
| other | Anxiety | Psychiatric disorders | Part 1 Arm 1 - Volixibat 20mg (Experimental) | 0 | 2 | 0 |
| other | Anxiety | Psychiatric disorders | Part 1 Arm 2 - Volixibat 80mg (Experimental) | 1 | 2 | 1 |
| other | Anxiety | Psychiatric disorders | Part 2 Arm 1 - Volixibat Selected Dose mg (Experimental) | 0 | ||
| other | Anxiety | Psychiatric disorders | Part 2 Arm 2 - Placebo (Placebo Comparator) | 0 | ||
| other | Apnoic Episodes | Respiratory, thoracic and mediastinal disorders | Part 1 Arm 1 - Volixibat 20mg (Experimental) | 0 | 2 | 0 |
| other | Apnoic Episodes | Respiratory, thoracic and mediastinal disorders | Part 1 Arm 2 - Volixibat 80mg (Experimental) | 1 | 2 | 1 |
| other | Apnoic Episodes | Respiratory, thoracic and mediastinal disorders | Part 2 Arm 1 - Volixibat Selected Dose mg (Experimental) | 0 | ||
| other | Apnoic Episodes | Respiratory, thoracic and mediastinal disorders | Part 2 Arm 2 - Placebo (Placebo Comparator) | 0 | ||
| other | Diarrhoea | Gastrointestinal disorders | Part 1 Arm 1 - Volixibat 20mg (Experimental) | 1 | 2 | 1 |
| other | Diarrhoea | Gastrointestinal disorders | Part 1 Arm 2 - Volixibat 80mg (Experimental) | 2 | 2 | 3 |
| other | Diarrhoea | Gastrointestinal disorders | Part 2 Arm 1 - Volixibat Selected Dose mg (Experimental) | 0 | ||
| other | Diarrhoea | Gastrointestinal disorders | Part 2 Arm 2 - Placebo (Placebo Comparator) | 0 | ||
| other | Gastroenteritis | Infections and infestations | Part 1 Arm 1 - Volixibat 20mg (Experimental) | 1 | 2 | 1 |
| other | Gastroenteritis | Infections and infestations | Part 1 Arm 2 - Volixibat 80mg (Experimental) | 0 | 2 | 0 |
| other | Gastroenteritis | Infections and infestations | Part 2 Arm 1 - Volixibat Selected Dose mg (Experimental) | 0 | ||
| other | Gastroenteritis | Infections and infestations | Part 2 Arm 2 - Placebo (Placebo Comparator) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04718961/events